Litcius/Paper detail

Assessment of Sacsin Turnover in Patients With ARSACS

Fabiana Longo, Daniele De Ritis, Annarita Miluzio, Davide Fraticelli, Jonathan Baets, Marina Scarlato, Filippo M. Santorelli, Stefano Biffo, Francesca Maltecca

2021Neurology24 citationsDOIOpen Access PDF

Abstract

BACKGROUND AND OBJECTIVES: variations with the age at onset or with disease severity, although not considering the effect of the various variations on protein stability. In this work, we studied genotype-phenotype correlation in ARSACS at a functional level. METHODS: We analyzed a large set of skin fibroblasts derived from patients with ARSACS, including both new and already published cases, carrying variations of different types affecting diverse domains of the protein. RESULTS: mRNA decay, defective translation, or faster posttranslational degradation as possible causes of protein reduction. Conversely, our results demonstrate that nascent mutant sacsin protein undergoes cotranslational ubiquitination and degradation. DISCUSSION: Our results provide a mechanistic explanation for the lack of genotype-phenotype correlation in ARSACS. We also propose a new and unambiguous criterion for ARSACS diagnosis that is based on the evaluation of sacsin level. Last, we identified preemptive degradation of a mutant protein as a novel cause of a human disease.

Topics & Concepts

MedicineIntensive care medicineMEDLINEInternal medicineProtein turnoverMutationProcess (computing)CorrelationMutantHuman proteinsBioinformaticsCellular transport and secretionProtease and Inhibitor MechanismsProtein Kinase Regulation and GTPase Signaling